Address
Novartis Venture Funds
Novartis International AG WSJ-200.220 P.O. Box
4002 Basel
Switzerland
Phone
Industry
Recent investment activity
KANDO id: 30987
Company type
The corporate venturing arm of Novartis.Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 26 - 49 of 49| Company | Profile | Country | Date Sort ascending | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Sirtris Pharmaceuticals Inc | Series C | ||||
|
|
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series B | |||
|
|
Nereus Pharmaceuticals Inc | N/A | ||||
|
|
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series A | |||
|
|
ESBATech AG | Switzerland based Biomedical Research Unit of Alcon | N/A Initial investment | |||
|
|
Nereus Pharmaceuticals Inc | Series B | ||||
|
|
Lumenos Inc | Provider of consumer-driven health care plans. | N/A | |||
|
|
Tokai Pharmaceuticals Inc | Developer of prostate cancer drugs | N/A | |||
|
|
Aileron Therapeutics Inc | Developing a breakthrough proprietary peptide technology platform | N/A | |||
|
|
Alnylam Pharmaceuticals Inc | N/A | ||||
|
|
Celladon Corp | N/A | ||||
|
|
Proteus Biomedical Inc | Cardiac diagnostic devices | N/A | |||
|
|
LigoCyte Pharmaceuticals Inc | N/A | ||||
|
|
IRX Therapeutics Inc | N/A | ||||
|
|
Avila Therapeutics Inc | A biotechnology company, pioneering a method to discover and develop new small-molecule medicines that achieve 'protein silencing'. | N/A | |||
|
|
Advanced Animal Diagnostics Inc | Develops rapid diagnostic tools to detect and manage disease states, reproductive, nutritional and overall health status of livestock animals. | N/A | |||
|
|
Viamet Pharmaceuticals Inc | N/A | ||||
|
|
BioRelix Inc | Advanced fight against drug resistant microbes by attacking novel targets with novel drugs. | Seed Initial investment | |||
|
Portaero Inc | N/A | ||||
|
|
Autonomic Technologies Inc | N/A | ||||
|
|
Okairos AG | N/A | ||||
|
|
Forma Therapeutics Inc | N/A | ||||
|
|
Panomics Inc | Develops novel cell-based assays and tools to enable multiplexed measurements of molecular events in a quantitative and scalable manner | N/A | |||
|
|
Ablation Frontiers Inc | Medical device company that has developed and marketed cardiac ablation devices. | N/A |